nod1 agonist tri dap Search Results


90
Bio-Techne corporation recombinant human nod1 gst (n-term) protein
Recombinant Human Nod1 Gst (N Term) Protein, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nod1+agonist+tri+dap/Recombinant+Human+NOD1+GST+(N-Term)+Protein/bio-techne+corporation___h00010392-p01
Average 90 stars, based on 1 article reviews
recombinant human nod1 gst (n-term) protein - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

95
Thermo Fisher nod1 ligand γd glutamyl meso diaminopimelic acid tri dap
Nod1 Ligand γd Glutamyl Meso Diaminopimelic Acid Tri Dap, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nod1+agonist+tri+dap/DAPTOMYCIN/pm38531608-70-23-28
Average 95 stars, based on 1 article reviews
nod1 ligand γd glutamyl meso diaminopimelic acid tri dap - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

90
Ribobio co sirnas targeting rig-i, mda5, mavs, and nod1
Sirnas Targeting Rig I, Mda5, Mavs, And Nod1, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nod1+agonist+tri+dap/sirnas+targeting+rig+i++mda5++mavs++and+nod1/pm38095472-336-9-26
Average 90 stars, based on 1 article reviews
sirnas targeting rig-i, mda5, mavs, and nod1 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Prantner GmbH partial knockdown of nod1
Partial Knockdown Of Nod1, supplied by Prantner GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nod1+agonist+tri+dap/nucleotide+binding+oligomerization+domain+1++nod1+/pm27421958-107-14-4
Average 90 stars, based on 1 article reviews
partial knockdown of nod1 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Bio-Techne corporation human nod1 antibody
Human Nod1 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nod1+agonist+tri+dap/Human+NOD1+Antibody/bio-techne+corporation___mab7090
Average 90 stars, based on 1 article reviews
human nod1 antibody - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Broad Institute Inc hairpin sequences specific for nod1
BCR editing and <t>Nod1</t> increase in mature B cells. (A) B220 + B cell analysis of V H 3609t knockout mice crossed with V K 21-5 Tg mice (V H 3609 +/− V k 21-5 +/− ) on either Thy WT or Thy KO background. Gated unedited ATA B in the spleen and PerC (red diagonal, with percentage) for phenotype analysis, and in vitro 2 d Thy M antigen stimulation outcome analysis with spleen ATA B. Thy M , thymocyte plasma membrane . PerC IgM + IgD lo/− ATA B cells in Thy WT were CD5 + as B1a. (B) Relative ATA serum titer determined by a thymocyte staining assay. Nontransgenic CB17 mouse sera (at 1:100 dilution) was set to 1.0 as the staining background. (C) V H 3609t × V K 21-5 Tg.Thy KO mouse spleen B cell analysis comparing transitional and mature B cells. Percentage of endogenous IgM (IgM b+ ), VDJ engineered IgM (IgM a+ ), VDJ-expressing B cells (V H 3609id + ), and unedited ATA B cells (ATAid hi ), out of total IgM (IgM a + IgM b ). ATAid hi B cell decrease with V H 3609id retention (center; n = 3; *, P < 0.01), generating L chain–edited ATAid lo FO B and MZ B cells (right). (D) Auto + AGcA B cell presence in L chain–edited B cells, including in FO B cells under Thy KO (Table S1). (E) In FO B cells under Thy KO , ATA B (1) and edited B cell fractions (2 and 3) for Nod1 quantitative PCR analysis, together with WT FO B cells ( n = 5; mean ± SE; *, P < 0.05; **, P < 0.005; ***, P < 0.001), and 6-h stimulation with CiE-DAP or anti-IgM. Unstimulated B cells shown as a dotted line. (F) Nonedited ATA B and edited B cell frequencies in total PBL B cells during aging in V H 3609t × V K 21-5 Tg.Thy KO mice ( n = 10–15 of each age group; mean ± SE).
Hairpin Sequences Specific For Nod1, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nod1+agonist+tri+dap/hairpin+sequences+specific+for+nod1/pmc05626402-235-4-8
Average 90 stars, based on 1 article reviews
hairpin sequences specific for nod1 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Millennium Pharmaceuticals nod1–/– mice
BCR editing and <t>Nod1</t> increase in mature B cells. (A) B220 + B cell analysis of V H 3609t knockout mice crossed with V K 21-5 Tg mice (V H 3609 +/− V k 21-5 +/− ) on either Thy WT or Thy KO background. Gated unedited ATA B in the spleen and PerC (red diagonal, with percentage) for phenotype analysis, and in vitro 2 d Thy M antigen stimulation outcome analysis with spleen ATA B. Thy M , thymocyte plasma membrane . PerC IgM + IgD lo/− ATA B cells in Thy WT were CD5 + as B1a. (B) Relative ATA serum titer determined by a thymocyte staining assay. Nontransgenic CB17 mouse sera (at 1:100 dilution) was set to 1.0 as the staining background. (C) V H 3609t × V K 21-5 Tg.Thy KO mouse spleen B cell analysis comparing transitional and mature B cells. Percentage of endogenous IgM (IgM b+ ), VDJ engineered IgM (IgM a+ ), VDJ-expressing B cells (V H 3609id + ), and unedited ATA B cells (ATAid hi ), out of total IgM (IgM a + IgM b ). ATAid hi B cell decrease with V H 3609id retention (center; n = 3; *, P < 0.01), generating L chain–edited ATAid lo FO B and MZ B cells (right). (D) Auto + AGcA B cell presence in L chain–edited B cells, including in FO B cells under Thy KO (Table S1). (E) In FO B cells under Thy KO , ATA B (1) and edited B cell fractions (2 and 3) for Nod1 quantitative PCR analysis, together with WT FO B cells ( n = 5; mean ± SE; *, P < 0.05; **, P < 0.005; ***, P < 0.001), and 6-h stimulation with CiE-DAP or anti-IgM. Unstimulated B cells shown as a dotted line. (F) Nonedited ATA B and edited B cell frequencies in total PBL B cells during aging in V H 3609t × V K 21-5 Tg.Thy KO mice ( n = 10–15 of each age group; mean ± SE).
Nod1–/– Mice, supplied by Millennium Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nod1+agonist+tri+dap/nod1+++++mice/pm16978234-167-0-2
Average 90 stars, based on 1 article reviews
nod1–/– mice - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

86
Hasegawa Co Ltd nod1
BCR editing and <t>Nod1</t> increase in mature B cells. (A) B220 + B cell analysis of V H 3609t knockout mice crossed with V K 21-5 Tg mice (V H 3609 +/− V k 21-5 +/− ) on either Thy WT or Thy KO background. Gated unedited ATA B in the spleen and PerC (red diagonal, with percentage) for phenotype analysis, and in vitro 2 d Thy M antigen stimulation outcome analysis with spleen ATA B. Thy M , thymocyte plasma membrane . PerC IgM + IgD lo/− ATA B cells in Thy WT were CD5 + as B1a. (B) Relative ATA serum titer determined by a thymocyte staining assay. Nontransgenic CB17 mouse sera (at 1:100 dilution) was set to 1.0 as the staining background. (C) V H 3609t × V K 21-5 Tg.Thy KO mouse spleen B cell analysis comparing transitional and mature B cells. Percentage of endogenous IgM (IgM b+ ), VDJ engineered IgM (IgM a+ ), VDJ-expressing B cells (V H 3609id + ), and unedited ATA B cells (ATAid hi ), out of total IgM (IgM a + IgM b ). ATAid hi B cell decrease with V H 3609id retention (center; n = 3; *, P < 0.01), generating L chain–edited ATAid lo FO B and MZ B cells (right). (D) Auto + AGcA B cell presence in L chain–edited B cells, including in FO B cells under Thy KO (Table S1). (E) In FO B cells under Thy KO , ATA B (1) and edited B cell fractions (2 and 3) for Nod1 quantitative PCR analysis, together with WT FO B cells ( n = 5; mean ± SE; *, P < 0.05; **, P < 0.005; ***, P < 0.001), and 6-h stimulation with CiE-DAP or anti-IgM. Unstimulated B cells shown as a dotted line. (F) Nonedited ATA B and edited B cell frequencies in total PBL B cells during aging in V H 3609t × V K 21-5 Tg.Thy KO mice ( n = 10–15 of each age group; mean ± SE).
Nod1, supplied by Hasegawa Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nod1+agonist+tri+dap/deficient+nod1/schneider_melinda_a__2015__nod1_nod2_receptors_modulate_the_microbiota_gut_brain_axis-78-2-14
Average 86 stars, based on 1 article reviews
nod1 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

90
Emerald BioSystems Inc wizard i screen
BCR editing and <t>Nod1</t> increase in mature B cells. (A) B220 + B cell analysis of V H 3609t knockout mice crossed with V K 21-5 Tg mice (V H 3609 +/− V k 21-5 +/− ) on either Thy WT or Thy KO background. Gated unedited ATA B in the spleen and PerC (red diagonal, with percentage) for phenotype analysis, and in vitro 2 d Thy M antigen stimulation outcome analysis with spleen ATA B. Thy M , thymocyte plasma membrane . PerC IgM + IgD lo/− ATA B cells in Thy WT were CD5 + as B1a. (B) Relative ATA serum titer determined by a thymocyte staining assay. Nontransgenic CB17 mouse sera (at 1:100 dilution) was set to 1.0 as the staining background. (C) V H 3609t × V K 21-5 Tg.Thy KO mouse spleen B cell analysis comparing transitional and mature B cells. Percentage of endogenous IgM (IgM b+ ), VDJ engineered IgM (IgM a+ ), VDJ-expressing B cells (V H 3609id + ), and unedited ATA B cells (ATAid hi ), out of total IgM (IgM a + IgM b ). ATAid hi B cell decrease with V H 3609id retention (center; n = 3; *, P < 0.01), generating L chain–edited ATAid lo FO B and MZ B cells (right). (D) Auto + AGcA B cell presence in L chain–edited B cells, including in FO B cells under Thy KO (Table S1). (E) In FO B cells under Thy KO , ATA B (1) and edited B cell fractions (2 and 3) for Nod1 quantitative PCR analysis, together with WT FO B cells ( n = 5; mean ± SE; *, P < 0.05; **, P < 0.005; ***, P < 0.001), and 6-h stimulation with CiE-DAP or anti-IgM. Unstimulated B cells shown as a dotted line. (F) Nonedited ATA B and edited B cell frequencies in total PBL B cells during aging in V H 3609t × V K 21-5 Tg.Thy KO mice ( n = 10–15 of each age group; mean ± SE).
Wizard I Screen, supplied by Emerald BioSystems Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nod1+agonist+tri+dap/wizard+screens+i/pmc01821002-115-5-14
Average 90 stars, based on 1 article reviews
wizard i screen - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

94
Thermo Fisher gene exp nod1 hs00196075 m1
Expression of Nod subtypes in corneal epithelial cells. A : The relative expression of <t>Nod1</t> , Nod2 , NLRC5 , and NLRX1 mRNA in HCE-T cells and in primary corneal epithelial cells derived from five individuals were measured and documented as described in the legend of . B : Detection of phosphorylated IκB using western blotting is illustrated. HCE-T cells were treated with 4 μg/ml ultrapure PGN-ECndss for the indicated time periods. The control THP-1 cells (c) were treated with 1 μg/ml LPS for 4 h. Equal amount of sample loading was verified by detecting β-actin protein expression.
Gene Exp Nod1 Hs00196075 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nod1+agonist+tri+dap/Gene+Exp%2E+NOD1%2C+Hs00196075_m1/pmc02526096-61-20--1
Average 94 stars, based on 1 article reviews
gene exp nod1 hs00196075 m1 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

90
Gallus BioPharmaceuticals gg-nod1
Human NLR sequences used for analyses
Gg Nod1, supplied by Gallus BioPharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nod1+agonist+tri+dap/gallus+domestics+nod1/pmc02268669-95-6-0
Average 90 stars, based on 1 article reviews
gg-nod1 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Bio-Techne corporation nod1 antibody
Human NLR sequences used for analyses
Nod1 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nod1+agonist+tri+dap/NOD1+Antibody/bio-techne+corporation___nb100-56878
Average 90 stars, based on 1 article reviews
nod1 antibody - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


BCR editing and Nod1 increase in mature B cells. (A) B220 + B cell analysis of V H 3609t knockout mice crossed with V K 21-5 Tg mice (V H 3609 +/− V k 21-5 +/− ) on either Thy WT or Thy KO background. Gated unedited ATA B in the spleen and PerC (red diagonal, with percentage) for phenotype analysis, and in vitro 2 d Thy M antigen stimulation outcome analysis with spleen ATA B. Thy M , thymocyte plasma membrane . PerC IgM + IgD lo/− ATA B cells in Thy WT were CD5 + as B1a. (B) Relative ATA serum titer determined by a thymocyte staining assay. Nontransgenic CB17 mouse sera (at 1:100 dilution) was set to 1.0 as the staining background. (C) V H 3609t × V K 21-5 Tg.Thy KO mouse spleen B cell analysis comparing transitional and mature B cells. Percentage of endogenous IgM (IgM b+ ), VDJ engineered IgM (IgM a+ ), VDJ-expressing B cells (V H 3609id + ), and unedited ATA B cells (ATAid hi ), out of total IgM (IgM a + IgM b ). ATAid hi B cell decrease with V H 3609id retention (center; n = 3; *, P < 0.01), generating L chain–edited ATAid lo FO B and MZ B cells (right). (D) Auto + AGcA B cell presence in L chain–edited B cells, including in FO B cells under Thy KO (Table S1). (E) In FO B cells under Thy KO , ATA B (1) and edited B cell fractions (2 and 3) for Nod1 quantitative PCR analysis, together with WT FO B cells ( n = 5; mean ± SE; *, P < 0.05; **, P < 0.005; ***, P < 0.001), and 6-h stimulation with CiE-DAP or anti-IgM. Unstimulated B cells shown as a dotted line. (F) Nonedited ATA B and edited B cell frequencies in total PBL B cells during aging in V H 3609t × V K 21-5 Tg.Thy KO mice ( n = 10–15 of each age group; mean ± SE).

Journal: The Journal of Experimental Medicine

Article Title: NLR Nod1 signaling promotes survival of BCR-engaged mature B cells through up-regulated Nod1 as a positive outcome

doi: 10.1084/jem.20170497

Figure Lengend Snippet: BCR editing and Nod1 increase in mature B cells. (A) B220 + B cell analysis of V H 3609t knockout mice crossed with V K 21-5 Tg mice (V H 3609 +/− V k 21-5 +/− ) on either Thy WT or Thy KO background. Gated unedited ATA B in the spleen and PerC (red diagonal, with percentage) for phenotype analysis, and in vitro 2 d Thy M antigen stimulation outcome analysis with spleen ATA B. Thy M , thymocyte plasma membrane . PerC IgM + IgD lo/− ATA B cells in Thy WT were CD5 + as B1a. (B) Relative ATA serum titer determined by a thymocyte staining assay. Nontransgenic CB17 mouse sera (at 1:100 dilution) was set to 1.0 as the staining background. (C) V H 3609t × V K 21-5 Tg.Thy KO mouse spleen B cell analysis comparing transitional and mature B cells. Percentage of endogenous IgM (IgM b+ ), VDJ engineered IgM (IgM a+ ), VDJ-expressing B cells (V H 3609id + ), and unedited ATA B cells (ATAid hi ), out of total IgM (IgM a + IgM b ). ATAid hi B cell decrease with V H 3609id retention (center; n = 3; *, P < 0.01), generating L chain–edited ATAid lo FO B and MZ B cells (right). (D) Auto + AGcA B cell presence in L chain–edited B cells, including in FO B cells under Thy KO (Table S1). (E) In FO B cells under Thy KO , ATA B (1) and edited B cell fractions (2 and 3) for Nod1 quantitative PCR analysis, together with WT FO B cells ( n = 5; mean ± SE; *, P < 0.05; **, P < 0.005; ***, P < 0.001), and 6-h stimulation with CiE-DAP or anti-IgM. Unstimulated B cells shown as a dotted line. (F) Nonedited ATA B and edited B cell frequencies in total PBL B cells during aging in V H 3609t × V K 21-5 Tg.Thy KO mice ( n = 10–15 of each age group; mean ± SE).

Article Snippet: Hairpin sequences specific for Nod1 were from the Broad Institute public TRC portal.

Techniques: Cell Analysis, Knock-Out, In Vitro, Clinical Proteomics, Membrane, Staining, Expressing, Real-time Polymerase Chain Reaction

Nod1 ligand signal–sensitive mature B cells increase with age in comparison to Xid mice . (A) Nod1 quantitative PCR in WT neonatal and adult B-lineage cells relative to self-antigen–unexposed adult ATA FO B cells from ATAμκTg.Thy KO mice (ATA FOB.Thy KO ), set to 1 ( n = 3–5, each group; mean ± SE; *, P < 0.05; **, P < 0.01; ***, P < 0.001). mat B, mature B; pB1a, PerC B1a; sB1a, spleen B1a. Right: Nod1 RT-PCR. (B) Anti-Nod1 cytoplasmic staining level comparison between ATA FO B.Thy KO cells and WT FO B cells ( n = 5; mean ± SE; *, P = 0.01). (C) CiE-DAP reactivity comparison between ATA FO B.Thy KO and WT mouse B cell subsets (representative of n = 4 each). (D) Top: Western blot of Nod1. Bottom: CiE-DAP–stimulated spleen cells in culture for 6 h. (E) Spleen cells stimulated with CiE-DAP, LPS, CpG, or medium alone (gray). Gating was based on IgM and IgD levels, together with AA4/CD93 and CD23. CiE-DAP–induced CD69 + cell frequency is shown. C.B17 mouse data were similar to B6 data (two mice each). (F) CiE-DAP–stimulated spleen cells from different-aged mice were stained with IgM, IgD, and CD69, and the frequency of CD69 + -activated cells among IgM med/lo IgD hi FO B cells (square region) is shown. Purified 5-wk and 2-mo FO B cells stimulated with CiE-DAP (right). C.B17, BALB, and C57BL/6 mice (three mice or more each) were analyzed, confirming similar results; data from C.B17 mice are shown. (G) Spleen and purified FO B cells in 2-mo-old Xid mice stimulated with CiE-DAP (left and middle). Nod1 quantitative PCR of Xid compared with WT mouse FO B cells (right; n = 3 each; mean ± SE; *, P < 0.003; **, P < 0.008).

Journal: The Journal of Experimental Medicine

Article Title: NLR Nod1 signaling promotes survival of BCR-engaged mature B cells through up-regulated Nod1 as a positive outcome

doi: 10.1084/jem.20170497

Figure Lengend Snippet: Nod1 ligand signal–sensitive mature B cells increase with age in comparison to Xid mice . (A) Nod1 quantitative PCR in WT neonatal and adult B-lineage cells relative to self-antigen–unexposed adult ATA FO B cells from ATAμκTg.Thy KO mice (ATA FOB.Thy KO ), set to 1 ( n = 3–5, each group; mean ± SE; *, P < 0.05; **, P < 0.01; ***, P < 0.001). mat B, mature B; pB1a, PerC B1a; sB1a, spleen B1a. Right: Nod1 RT-PCR. (B) Anti-Nod1 cytoplasmic staining level comparison between ATA FO B.Thy KO cells and WT FO B cells ( n = 5; mean ± SE; *, P = 0.01). (C) CiE-DAP reactivity comparison between ATA FO B.Thy KO and WT mouse B cell subsets (representative of n = 4 each). (D) Top: Western blot of Nod1. Bottom: CiE-DAP–stimulated spleen cells in culture for 6 h. (E) Spleen cells stimulated with CiE-DAP, LPS, CpG, or medium alone (gray). Gating was based on IgM and IgD levels, together with AA4/CD93 and CD23. CiE-DAP–induced CD69 + cell frequency is shown. C.B17 mouse data were similar to B6 data (two mice each). (F) CiE-DAP–stimulated spleen cells from different-aged mice were stained with IgM, IgD, and CD69, and the frequency of CD69 + -activated cells among IgM med/lo IgD hi FO B cells (square region) is shown. Purified 5-wk and 2-mo FO B cells stimulated with CiE-DAP (right). C.B17, BALB, and C57BL/6 mice (three mice or more each) were analyzed, confirming similar results; data from C.B17 mice are shown. (G) Spleen and purified FO B cells in 2-mo-old Xid mice stimulated with CiE-DAP (left and middle). Nod1 quantitative PCR of Xid compared with WT mouse FO B cells (right; n = 3 each; mean ± SE; *, P < 0.003; **, P < 0.008).

Article Snippet: Hairpin sequences specific for Nod1 were from the Broad Institute public TRC portal.

Techniques: Comparison, Real-time Polymerase Chain Reaction, Reverse Transcription Polymerase Chain Reaction, Staining, Western Blot, Purification

Nod1 up-regulation in BCR engaged B cells in vivo. (A) Rag1 and Rag2 quantitative PCR of ATA B cells under Thy KO and Thy WT in ATAμκTg mice ( n = 3; mean ± SE; *, P = 0.03; **, P = 0.003). (B) Rag1 and Rag2 quantitative PCR of ATA B cells and edited ATAid lo B cells in V H 3609t × V k 21-5Tg.Thy KO mice ( n = 3; mean ± SE; *, P = 0.1; **, P = 0.03). (C) Quantitative PCR of WT (C.B17) FO B cells stimulated with anti-IgM, LPS, or CpG during 24-h culture. Similar data were obtained by B6 FO B cell simulation (two samples each). (D) Ptpn22 quantitative PCR in B-lineage cells ( n = 3–5, each group; mean ± SE; *, P < 0.01; **, P < 0.002) and Western blot. (E) Nod1 and Ptpn22 quantitative PCR of ATAid + FO B cells sorted from ATAμκTg.Thy KO mice exposed to lck -Thy-1 Tg cells, Thy 10, or Thy 60 by breeding ( n = 3 each, 2–3 mo old; mean ± SE; *, P < 0.05), comparing ATAid + FO B cells without lck -Thy-1 Tg, as (−) 1.0, and Thy-1 Tg + in littermates. CiE-DAP reactivity comparison by ATAid + FO B cells without (−) and with lck -Thy 60 Tg littermates (middle). Ptpn22 up-regulation resulting from a BCR ligand signal, followed by Nod1 up-regulation, occurred in vivo (right). (F) Mature (AA4 − CD21 med CD23 + ) B cell Nod1 and Ptpn22 mRNA comparison ( n = 3 each; mean ± SE). WT mice used for comparison with LTα −/− .B6 mice were B6. CiE-DAP reactivity by mature B cells in CD40 −/− and Ltα −/− mice (right). (G) Comparison of Nod1 and Ptpn22 mRNA levels in immature stages of ATA B cells from V H 3609t × V K 21-5 Tg mice on Thy WT (black square) and Thy KO (open circle) backgrounds, and mature edited FO B cells (gray; n = 4; mean ± SE; *, P < 0.005; **, P < 0.01 for T1 comparison). (H) Edited B cells with Nod1 up-regulation as the outcome of BCR ligand engagement.

Journal: The Journal of Experimental Medicine

Article Title: NLR Nod1 signaling promotes survival of BCR-engaged mature B cells through up-regulated Nod1 as a positive outcome

doi: 10.1084/jem.20170497

Figure Lengend Snippet: Nod1 up-regulation in BCR engaged B cells in vivo. (A) Rag1 and Rag2 quantitative PCR of ATA B cells under Thy KO and Thy WT in ATAμκTg mice ( n = 3; mean ± SE; *, P = 0.03; **, P = 0.003). (B) Rag1 and Rag2 quantitative PCR of ATA B cells and edited ATAid lo B cells in V H 3609t × V k 21-5Tg.Thy KO mice ( n = 3; mean ± SE; *, P = 0.1; **, P = 0.03). (C) Quantitative PCR of WT (C.B17) FO B cells stimulated with anti-IgM, LPS, or CpG during 24-h culture. Similar data were obtained by B6 FO B cell simulation (two samples each). (D) Ptpn22 quantitative PCR in B-lineage cells ( n = 3–5, each group; mean ± SE; *, P < 0.01; **, P < 0.002) and Western blot. (E) Nod1 and Ptpn22 quantitative PCR of ATAid + FO B cells sorted from ATAμκTg.Thy KO mice exposed to lck -Thy-1 Tg cells, Thy 10, or Thy 60 by breeding ( n = 3 each, 2–3 mo old; mean ± SE; *, P < 0.05), comparing ATAid + FO B cells without lck -Thy-1 Tg, as (−) 1.0, and Thy-1 Tg + in littermates. CiE-DAP reactivity comparison by ATAid + FO B cells without (−) and with lck -Thy 60 Tg littermates (middle). Ptpn22 up-regulation resulting from a BCR ligand signal, followed by Nod1 up-regulation, occurred in vivo (right). (F) Mature (AA4 − CD21 med CD23 + ) B cell Nod1 and Ptpn22 mRNA comparison ( n = 3 each; mean ± SE). WT mice used for comparison with LTα −/− .B6 mice were B6. CiE-DAP reactivity by mature B cells in CD40 −/− and Ltα −/− mice (right). (G) Comparison of Nod1 and Ptpn22 mRNA levels in immature stages of ATA B cells from V H 3609t × V K 21-5 Tg mice on Thy WT (black square) and Thy KO (open circle) backgrounds, and mature edited FO B cells (gray; n = 4; mean ± SE; *, P < 0.005; **, P < 0.01 for T1 comparison). (H) Edited B cells with Nod1 up-regulation as the outcome of BCR ligand engagement.

Article Snippet: Hairpin sequences specific for Nod1 were from the Broad Institute public TRC portal.

Techniques: In Vivo, Real-time Polymerase Chain Reaction, Western Blot, Comparison

Nod1 signaling promotes survival of BCR ligand–experienced B cells. (A) Viability of FO B cells, 3 and 7 d in culture, stimulated with CiE-DAP, BAFF, or both. Total cell numbers were similar ( n = 3, mean ± SE). Data obtained in C57BL/6 mouse FO B cells were similar (two samples). (B) Analysis at 6 h and 3 d after stimulation of purified B cell subsets from WT mouse. After 6 h, comparison of CD69 level by PE–anti-CD69 staining (PE mean level). For 3-d analysis, CSFE labeling of purified B cells was used for analysis of cell division and viability (%). Representative data (C.B17 mice) from seven experiments with C.B17 and BALB/c, and five experiments with C57BL/6 are shown. All showed increased viability with CiE-DAP ( n = 2, mean ± SE). (C) Nod1 and Ptpn22 mRNA comparison between (1) ATA FO B from ATAμκTg.Thy KO mice (auto − ), (2) FO B cells from WT mice, and (3 and 4) AGcA FO B and MZ B cells from AGcAμκTg mice (auto + ), respectively (all on a C.B17 background; n = 3 each; mean ± SE; *, P < 0.05). (D) B cells, listed in C, were stimulated for 6 h to 3 d by CiE-DAP (thin line), anti-IgM (thick line), and CiE-DAP plus anti-IgM (dotted line). On day 3, cell size (flow cytometry scatter) and percent viability were determined. Four experiments showed similar results. (E) Increased viability and cell size by CiE-DAP stimulation through the Nod1–Ripk2 signal in WT (B6) FO B cells.

Journal: The Journal of Experimental Medicine

Article Title: NLR Nod1 signaling promotes survival of BCR-engaged mature B cells through up-regulated Nod1 as a positive outcome

doi: 10.1084/jem.20170497

Figure Lengend Snippet: Nod1 signaling promotes survival of BCR ligand–experienced B cells. (A) Viability of FO B cells, 3 and 7 d in culture, stimulated with CiE-DAP, BAFF, or both. Total cell numbers were similar ( n = 3, mean ± SE). Data obtained in C57BL/6 mouse FO B cells were similar (two samples). (B) Analysis at 6 h and 3 d after stimulation of purified B cell subsets from WT mouse. After 6 h, comparison of CD69 level by PE–anti-CD69 staining (PE mean level). For 3-d analysis, CSFE labeling of purified B cells was used for analysis of cell division and viability (%). Representative data (C.B17 mice) from seven experiments with C.B17 and BALB/c, and five experiments with C57BL/6 are shown. All showed increased viability with CiE-DAP ( n = 2, mean ± SE). (C) Nod1 and Ptpn22 mRNA comparison between (1) ATA FO B from ATAμκTg.Thy KO mice (auto − ), (2) FO B cells from WT mice, and (3 and 4) AGcA FO B and MZ B cells from AGcAμκTg mice (auto + ), respectively (all on a C.B17 background; n = 3 each; mean ± SE; *, P < 0.05). (D) B cells, listed in C, were stimulated for 6 h to 3 d by CiE-DAP (thin line), anti-IgM (thick line), and CiE-DAP plus anti-IgM (dotted line). On day 3, cell size (flow cytometry scatter) and percent viability were determined. Four experiments showed similar results. (E) Increased viability and cell size by CiE-DAP stimulation through the Nod1–Ripk2 signal in WT (B6) FO B cells.

Article Snippet: Hairpin sequences specific for Nod1 were from the Broad Institute public TRC portal.

Techniques: Purification, Comparison, Staining, Labeling, Flow Cytometry

Nod1-mediated NF-κB, PI3K, and MAPK signals in B cells. (A) Western blot of WT (B6) mouse (left) and WT, Ripk2 −/− , and Nod1 −/− FO B cells (right) stimulated with CiE-DAP, showing Nod1- and Ripk2-dependent IκBα phosphorylation. (B) Activation of MAPK by CiE-DAP stimulation. (C) Nod1-dependent Akt Ser473/Thr308 phosphorylation in CiE-DAP–stimulated FO B cells. (D) The PI3K inhibitor LY294002 inhibits Akt phosphorylation induced by CiE-DAP stimulation. (E) FO B cell stimulation with CiE-DAP from 5 min to 24 h, and kinetic analysis of phosphorylated Akt, FoxO1, and Gsk3β. Initial phosphorylated Akt was transient, declining after 1 h and then recovering. (F) Comparison of CiE-DAP–mediated Nod1 signal–induced IκBα degradation in different B cell subsets. Samples 1–4 were the same as in (1–4). Sample 5 was autoreactive B1a from V H 11 knock-in mice (auto + ; ) and the lowest (or negative) by auto − FO B cells. (G) Summary of Western blot results of Nod1, BCR, and Nod1-BCR signaling of FO B, MZ B, and B1a B cells. β-Actin levels were all similar within each Western blot. Nod1-BCR co-stimulation consistently increased the NF-κB and JNK signal for WT FO B cells and overrode autoreactive B cell tolerance. Shown are representative data from two to three experiments for each B cell stimulation.

Journal: The Journal of Experimental Medicine

Article Title: NLR Nod1 signaling promotes survival of BCR-engaged mature B cells through up-regulated Nod1 as a positive outcome

doi: 10.1084/jem.20170497

Figure Lengend Snippet: Nod1-mediated NF-κB, PI3K, and MAPK signals in B cells. (A) Western blot of WT (B6) mouse (left) and WT, Ripk2 −/− , and Nod1 −/− FO B cells (right) stimulated with CiE-DAP, showing Nod1- and Ripk2-dependent IκBα phosphorylation. (B) Activation of MAPK by CiE-DAP stimulation. (C) Nod1-dependent Akt Ser473/Thr308 phosphorylation in CiE-DAP–stimulated FO B cells. (D) The PI3K inhibitor LY294002 inhibits Akt phosphorylation induced by CiE-DAP stimulation. (E) FO B cell stimulation with CiE-DAP from 5 min to 24 h, and kinetic analysis of phosphorylated Akt, FoxO1, and Gsk3β. Initial phosphorylated Akt was transient, declining after 1 h and then recovering. (F) Comparison of CiE-DAP–mediated Nod1 signal–induced IκBα degradation in different B cell subsets. Samples 1–4 were the same as in (1–4). Sample 5 was autoreactive B1a from V H 11 knock-in mice (auto + ; ) and the lowest (or negative) by auto − FO B cells. (G) Summary of Western blot results of Nod1, BCR, and Nod1-BCR signaling of FO B, MZ B, and B1a B cells. β-Actin levels were all similar within each Western blot. Nod1-BCR co-stimulation consistently increased the NF-κB and JNK signal for WT FO B cells and overrode autoreactive B cell tolerance. Shown are representative data from two to three experiments for each B cell stimulation.

Article Snippet: Hairpin sequences specific for Nod1 were from the Broad Institute public TRC portal.

Techniques: Western Blot, Phospho-proteomics, Activation Assay, Cell Stimulation, Comparison, Knock-In

Continued B cell survival in aged mice by transduced Nod1 expression. (A) Transfer of nonedited auto − ATAμκTg.Thy KO mouse BM with Nod1-GFP or pMIG (without Nod1)-GFP as a control. Comparison of GFP + cell frequency in ATA B cells between the FO B cell and T1 stage (as a ratio) in PBLs at 3 wk ( n = 6 each; mean ± SE) and spleen at 6 wk. In the 6-wk GFP histogram, immature B cells in BM (1) are shown in gray, along with GFP + frequency. Data are representative of n = 6 each. (B) Increase in the number of Nod1-GFP + cells in the ATA FO B cell pool under Thy KO . (C) Transfer of edited V H 3609t × V k 21-5 Tg.Thy KO mouse BM with Nod1-GFP or control-GFP into Rag KO Thy KO recipients. Spleen B cell analysis 6 wk after transfer, comparing GFP + and GFP − B cell subsets, with percentage of edited ATAid lo cells (middle). Nod1-GFP transfected B cell data (right; n = 3 each; mean ± SE). (D) PBL B cell analysis during aging (and spleen in aged mice) after transfer with Nod1-GFP V H 3609t × V K 21-5 Tg.Thy KO mouse BM. After transfer, the WT/knockout mouse B cell ratio levels in spleen were based on the WT/knockout mouse B cell ratio level data of T1 (CD19 + IgM hi AA4 + CD21 − CD23 − as 1.0. IgM/IgD phenotype of GFP + B cells (right). Unchanged IgM med level by Nod1-GFP + hi auto − ATA B cells 12 mo after transfer, in comparison with edited GFP + med B cells with IgM lo B cells. Data are representative of three recipients. (E) Increased survival outcome by FO B cells in aged mice by Nod1 up-regulation. IgM lo IgD + FO B cells are predominantly BCR signal–experienced Nod1 + B cells.

Journal: The Journal of Experimental Medicine

Article Title: NLR Nod1 signaling promotes survival of BCR-engaged mature B cells through up-regulated Nod1 as a positive outcome

doi: 10.1084/jem.20170497

Figure Lengend Snippet: Continued B cell survival in aged mice by transduced Nod1 expression. (A) Transfer of nonedited auto − ATAμκTg.Thy KO mouse BM with Nod1-GFP or pMIG (without Nod1)-GFP as a control. Comparison of GFP + cell frequency in ATA B cells between the FO B cell and T1 stage (as a ratio) in PBLs at 3 wk ( n = 6 each; mean ± SE) and spleen at 6 wk. In the 6-wk GFP histogram, immature B cells in BM (1) are shown in gray, along with GFP + frequency. Data are representative of n = 6 each. (B) Increase in the number of Nod1-GFP + cells in the ATA FO B cell pool under Thy KO . (C) Transfer of edited V H 3609t × V k 21-5 Tg.Thy KO mouse BM with Nod1-GFP or control-GFP into Rag KO Thy KO recipients. Spleen B cell analysis 6 wk after transfer, comparing GFP + and GFP − B cell subsets, with percentage of edited ATAid lo cells (middle). Nod1-GFP transfected B cell data (right; n = 3 each; mean ± SE). (D) PBL B cell analysis during aging (and spleen in aged mice) after transfer with Nod1-GFP V H 3609t × V K 21-5 Tg.Thy KO mouse BM. After transfer, the WT/knockout mouse B cell ratio levels in spleen were based on the WT/knockout mouse B cell ratio level data of T1 (CD19 + IgM hi AA4 + CD21 − CD23 − as 1.0. IgM/IgD phenotype of GFP + B cells (right). Unchanged IgM med level by Nod1-GFP + hi auto − ATA B cells 12 mo after transfer, in comparison with edited GFP + med B cells with IgM lo B cells. Data are representative of three recipients. (E) Increased survival outcome by FO B cells in aged mice by Nod1 up-regulation. IgM lo IgD + FO B cells are predominantly BCR signal–experienced Nod1 + B cells.

Article Snippet: Hairpin sequences specific for Nod1 were from the Broad Institute public TRC portal.

Techniques: Expressing, Control, Comparison, Cell Analysis, Transfection, Knock-Out

Competitive survival by mature B cells promoted by Nod1–Ripk2 signaling. (A) FO B/T1 GFP + AGcA B cell ratio in spleen 5–6 wk after transfer of AGcATg mouse BM with shNod1-GFP or LMP (without shNod1)-GFP as a control ( n = 3 each; mean ± SE; *, P = 0.008). (B) Spleen cell analysis (IgM/IgD) and stimulation with CiE-DAP, muramyl dipeptide (Nod2 ligand), and LPS, comparing WT (B6) and Nod1/2 −/− mice. (C) Ripk2 −/− mouse FO B cell Nod1 and Ptpn22 levels in comparison with Ripk2 +/+ littermates (middle; quantitative PCR; n = 3 each; mean ± SE). Ripk2 −/− FO B stimulation analysis (right). (D) Chimeric transfer of WT (Ly5.1) and Nod1/2 −/− (Ly5.2) mouse BM at a 1:1 ratio. Initial (4 wk) chimeric transfer ratio was set to 1:1 at the IgM + IgD lo AA4 + transitional cell stage (“1”) in PBL. In spleen, the WT/Nod1/2 −/− ratio was based on the T1 in each mouse ( n = 3; mean ± SE). (E) Chimeric transfer of WT and Ripk2 −/− mouse BM, as done with Nod1/2 −/− mice in D ( n = 4; mean ± SE). (F) Splenic B cells in AGcAμκTg.B6 mice without or with Ripk2 deficiency. Similar AGcA B cell dominance per number and CD21 hi MZ B cell frequency. Representative of three mice each. (G) Chimeric transfer of WT (B6) and AGcAμκTg (Ripk2 +/+ or Ripk2 −/− ) BM at a 3:1 ratio, followed by splenic B cell analysis. Frequencies of AGcA B cells (as marked, also V k 19-17 recognizing 13H8k + ) in total B cells and CD21 hi cells among AGcA B cells are shown ( n = 3; mean ± SE). (H) 1:1 chimeric transfer of purified B cells from Ripk2 +/+ WT and Ripk2 −/− mouse spleen, followed by analysis of PBL B cells and IgM hi IgD lo AA4 − cells in PBL at 12 wk ( n = 3, mean ± SE). (I) The microenvironment, including BCR ligands, BAFF, and microbial products, plays a role in mature B cell survival. BCR ligand–mediated Nod1 up-regulation, but without maturation arrest, leads to preferential mature B cell survival as a competitive survival, increasing the Nod1 + B cell pool with age.

Journal: The Journal of Experimental Medicine

Article Title: NLR Nod1 signaling promotes survival of BCR-engaged mature B cells through up-regulated Nod1 as a positive outcome

doi: 10.1084/jem.20170497

Figure Lengend Snippet: Competitive survival by mature B cells promoted by Nod1–Ripk2 signaling. (A) FO B/T1 GFP + AGcA B cell ratio in spleen 5–6 wk after transfer of AGcATg mouse BM with shNod1-GFP or LMP (without shNod1)-GFP as a control ( n = 3 each; mean ± SE; *, P = 0.008). (B) Spleen cell analysis (IgM/IgD) and stimulation with CiE-DAP, muramyl dipeptide (Nod2 ligand), and LPS, comparing WT (B6) and Nod1/2 −/− mice. (C) Ripk2 −/− mouse FO B cell Nod1 and Ptpn22 levels in comparison with Ripk2 +/+ littermates (middle; quantitative PCR; n = 3 each; mean ± SE). Ripk2 −/− FO B stimulation analysis (right). (D) Chimeric transfer of WT (Ly5.1) and Nod1/2 −/− (Ly5.2) mouse BM at a 1:1 ratio. Initial (4 wk) chimeric transfer ratio was set to 1:1 at the IgM + IgD lo AA4 + transitional cell stage (“1”) in PBL. In spleen, the WT/Nod1/2 −/− ratio was based on the T1 in each mouse ( n = 3; mean ± SE). (E) Chimeric transfer of WT and Ripk2 −/− mouse BM, as done with Nod1/2 −/− mice in D ( n = 4; mean ± SE). (F) Splenic B cells in AGcAμκTg.B6 mice without or with Ripk2 deficiency. Similar AGcA B cell dominance per number and CD21 hi MZ B cell frequency. Representative of three mice each. (G) Chimeric transfer of WT (B6) and AGcAμκTg (Ripk2 +/+ or Ripk2 −/− ) BM at a 3:1 ratio, followed by splenic B cell analysis. Frequencies of AGcA B cells (as marked, also V k 19-17 recognizing 13H8k + ) in total B cells and CD21 hi cells among AGcA B cells are shown ( n = 3; mean ± SE). (H) 1:1 chimeric transfer of purified B cells from Ripk2 +/+ WT and Ripk2 −/− mouse spleen, followed by analysis of PBL B cells and IgM hi IgD lo AA4 − cells in PBL at 12 wk ( n = 3, mean ± SE). (I) The microenvironment, including BCR ligands, BAFF, and microbial products, plays a role in mature B cell survival. BCR ligand–mediated Nod1 up-regulation, but without maturation arrest, leads to preferential mature B cell survival as a competitive survival, increasing the Nod1 + B cell pool with age.

Article Snippet: Hairpin sequences specific for Nod1 were from the Broad Institute public TRC portal.

Techniques: Control, Cell Analysis, Comparison, Real-time Polymerase Chain Reaction, Purification

Expression of Nod subtypes in corneal epithelial cells. A : The relative expression of Nod1 , Nod2 , NLRC5 , and NLRX1 mRNA in HCE-T cells and in primary corneal epithelial cells derived from five individuals were measured and documented as described in the legend of . B : Detection of phosphorylated IκB using western blotting is illustrated. HCE-T cells were treated with 4 μg/ml ultrapure PGN-ECndss for the indicated time periods. The control THP-1 cells (c) were treated with 1 μg/ml LPS for 4 h. Equal amount of sample loading was verified by detecting β-actin protein expression.

Journal: Molecular Vision

Article Title: Constitutive and UV-B modulated transcription of Nod-like receptors and their functional partners in human corneal epithelial cells

doi:

Figure Lengend Snippet: Expression of Nod subtypes in corneal epithelial cells. A : The relative expression of Nod1 , Nod2 , NLRC5 , and NLRX1 mRNA in HCE-T cells and in primary corneal epithelial cells derived from five individuals were measured and documented as described in the legend of . B : Detection of phosphorylated IκB using western blotting is illustrated. HCE-T cells were treated with 4 μg/ml ultrapure PGN-ECndss for the indicated time periods. The control THP-1 cells (c) were treated with 1 μg/ml LPS for 4 h. Equal amount of sample loading was verified by detecting β-actin protein expression.

Article Snippet: The following ABI-TaqMan assays were used in the studies: ASC-HS00203118, Caspase-1-Hs00354836, Caspase-5-Hs00362072, Cardinal-Hs00209095, Nalp1-Hs00248187, Nalp3-Hs00366461, Nalp2-Hs215284, Nalp7-Hs00373683, Nalp10-Hs738590, NLRC5-Hs00260008, NLRX1-Hs00226360, Nod1-Hs00196075, and Nod2-Hs00223394.

Techniques: Expressing, Derivative Assay, Western Blot

The effect of UV-B treatment on the expression of Nod subtypes in HCE-T cells. Changes of Nod mRNA expression 6 h ( A ) or 24 h ( B ) after UV-B treatment are shown. The relative expression of Nod1 , Nod2 , Nod4/Nod27 , and Nod5/Nod9 was measured in 85%–90% confluent HCE-T cells irradiated with 30 mJ/cm 2 UV-B as described in the legend of and is shown as compared to cells incubated in the same way but not irradiated. Mean values and ±SD were calculated from six independent measurements. The asterisk indicates a p<0.005.

Journal: Molecular Vision

Article Title: Constitutive and UV-B modulated transcription of Nod-like receptors and their functional partners in human corneal epithelial cells

doi:

Figure Lengend Snippet: The effect of UV-B treatment on the expression of Nod subtypes in HCE-T cells. Changes of Nod mRNA expression 6 h ( A ) or 24 h ( B ) after UV-B treatment are shown. The relative expression of Nod1 , Nod2 , Nod4/Nod27 , and Nod5/Nod9 was measured in 85%–90% confluent HCE-T cells irradiated with 30 mJ/cm 2 UV-B as described in the legend of and is shown as compared to cells incubated in the same way but not irradiated. Mean values and ±SD were calculated from six independent measurements. The asterisk indicates a p<0.005.

Article Snippet: The following ABI-TaqMan assays were used in the studies: ASC-HS00203118, Caspase-1-Hs00354836, Caspase-5-Hs00362072, Cardinal-Hs00209095, Nalp1-Hs00248187, Nalp3-Hs00366461, Nalp2-Hs215284, Nalp7-Hs00373683, Nalp10-Hs738590, NLRC5-Hs00260008, NLRX1-Hs00226360, Nod1-Hs00196075, and Nod2-Hs00223394.

Techniques: Expressing, Irradiation, Incubation

Human NLR sequences used for analyses

Journal: BMC Evolutionary Biology

Article Title: A genomic view of the NOD-like receptor family in teleost fish: identification of a novel NLR subfamily in zebrafish

doi: 10.1186/1471-2148-8-42

Figure Lengend Snippet: Human NLR sequences used for analyses

Article Snippet: Gallus gallus , Chr 2 , GG-NOD1 , NOD1 , ENSGALG00000011535 , CARD a.

Techniques:

NLR-SUBFAMILY A in zebrafish

Journal: BMC Evolutionary Biology

Article Title: A genomic view of the NOD-like receptor family in teleost fish: identification of a novel NLR subfamily in zebrafish

doi: 10.1186/1471-2148-8-42

Figure Lengend Snippet: NLR-SUBFAMILY A in zebrafish

Article Snippet: Gallus gallus , Chr 2 , GG-NOD1 , NOD1 , ENSGALG00000011535 , CARD a.

Techniques:

NLR subfamily genes identified in other non-mammalian genomes

Journal: BMC Evolutionary Biology

Article Title: A genomic view of the NOD-like receptor family in teleost fish: identification of a novel NLR subfamily in zebrafish

doi: 10.1186/1471-2148-8-42

Figure Lengend Snippet: NLR subfamily genes identified in other non-mammalian genomes

Article Snippet: Gallus gallus , Chr 2 , GG-NOD1 , NOD1 , ENSGALG00000011535 , CARD a.

Techniques:

Schematic diagram depicting the deduced protein structures of zebrafish NLRs. Zebrafish NLR subfamily-A have structures similar to the NOD subfamily in mammals, with NOD1/NLR-A1 possessing one CARD motif while NOD2/NLR-A2 possesses two. While only the NACHT domain was identified for most members of the NLR-B subfamily, one member of this group (NLR-B2) was predicted with a putative N-terminal CARD effector domain. All NLR-C subfamily members were predicted to have an N-terminal effector domain, a central NACHT domain and a LRR domain. In addition, some of the NLR-C molecules were identified with a C-terminal B30.2 domain. The predicted effector domains of molecules within the NLR-C subfamily varied; some had a pyrin (P) effector domain, while others had a distinct uncharacterized effector domain (X). B30.2 domains are also found in other important immune related molecules such as certain TRIMs and the Pyrin molecule, whose structures are also shown. C = card domain, P = pyrin domain, X = other domain, N = NACHT domain, L = LRR region, B = B30.2/PRY-SPRY domain, R = ring finger domain, BB = B-box, CC = coiled coil.

Journal: BMC Evolutionary Biology

Article Title: A genomic view of the NOD-like receptor family in teleost fish: identification of a novel NLR subfamily in zebrafish

doi: 10.1186/1471-2148-8-42

Figure Lengend Snippet: Schematic diagram depicting the deduced protein structures of zebrafish NLRs. Zebrafish NLR subfamily-A have structures similar to the NOD subfamily in mammals, with NOD1/NLR-A1 possessing one CARD motif while NOD2/NLR-A2 possesses two. While only the NACHT domain was identified for most members of the NLR-B subfamily, one member of this group (NLR-B2) was predicted with a putative N-terminal CARD effector domain. All NLR-C subfamily members were predicted to have an N-terminal effector domain, a central NACHT domain and a LRR domain. In addition, some of the NLR-C molecules were identified with a C-terminal B30.2 domain. The predicted effector domains of molecules within the NLR-C subfamily varied; some had a pyrin (P) effector domain, while others had a distinct uncharacterized effector domain (X). B30.2 domains are also found in other important immune related molecules such as certain TRIMs and the Pyrin molecule, whose structures are also shown. C = card domain, P = pyrin domain, X = other domain, N = NACHT domain, L = LRR region, B = B30.2/PRY-SPRY domain, R = ring finger domain, BB = B-box, CC = coiled coil.

Article Snippet: Gallus gallus , Chr 2 , GG-NOD1 , NOD1 , ENSGALG00000011535 , CARD a.

Techniques: